维普期刊资源整合服务平台（V6.5）

118篇 您的检索式：作者名="Dromer"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	隐球菌病处理临床实践指南:2010年美国感染病学会更新显示文摘为了帮助临床医师在治疗念珠菌病时正确选用抗真菌药,制订合理的给药方案。美国感染病学会(IDSA)组织相关学科的专家对2000年隐球菌病处理指南进行了修订。该指南发表在Clinical Infectious Disease,2010,50:291-322。由于该指南的更新仍是基于大量的临床证据,因此对指导临床正确合理治疗隐球菌病具有重要参考价值,现将其主要内容编译供参考。	周颖杰李光辉 Perfect JR Dismukes WE Dromer F	2010	中国感染与化疗杂志2010，10，3：	328
2	Primary cutaneous cryptococcosis: a distinct clinical entity显示文摘	Neuville S Dromer F Morin O	2003	Clin Infect Dis2003，36，3：	1
3	Cryptococcal cell morphology affects host cell interactions and pathogenicity显示文摘	Okagaki LH Strain AK Nielsen JN Charlier C Baltes NJ Chr6tien F Heitman J Dromer F Nielsen K	2010	PLoS Pathog2010，6，10：	1
4	Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious disease society of America显示文摘	PERFECT J R DISMUKES W E DROMER F	2010	Clin Infect Dis2010，50，3：	1
5	Determi- nants of disease presentation and outcome during cryptococ- cosis : the CryptoA/D study 显示文摘	Dromer F Mathoulin-Pelissier S Launay O	2007	PLos Med2007，4，2：	1
6	Does vascular endothelial growth factor in the rheumatoid synovium predict joint destruction? A clinical, radiological, and pathological study in 12 patients monitored for 10 years显示文摘	Latour F Zabraniecki L Dromer C	2001	Joint Bone Spine2001，68，6：	1
7	Clinical practice guidelines for the management of cryptococcal disease:2010 update by the infectious diseases society of America显示文摘	Perfect JR Dismukes WE Dromer FA	2010	Clinical Infectious Diseases2010，50，3：	1
8	Primary cutaneous cryptococcosis: a distinct clinical entity 显示文摘	Neuville S Dromer F Morin O	2003	Clin Infect Dis2003，36，3：	1
9	Cryptococcus neoformans Galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus Galactomannan显示文摘	Dalle F Charles PE Blanc K Caillot D Chavanet P Dromer F		0，，06：	1
10	Cryptococcosis:clinical and biological aspects显示文摘	Kwon-Chung KJ Sorrell TC Dromer F	2000	Med Mycol2000，38，1：	1
11	Clinical practice guidelines for the management of cryptococcal disease:2010 update by the infectious diseases society of America显示文摘	Perfect JR Dismukes WE Dromer F Goldman DL Graybill JR Hamill R J		0，，03：	1
12	Clinical practice guidelines for the management of Cryptococcosis disease: 2010 update by the infectious diseases society of america显示文摘	Perfect JR Dismukes WE Dromer F	2010	Clin Infect Dis2010，50，3：	1
13	Expanding wire stents in benign tracheobronchial disease:indications and complications显示文摘	Nashef SA Dromer C Velly JF	1992	Ann Thorac Surg1992，54，5：	1
14	Primary cutaneous cryptococcosis:a distinct clinical entity显示文摘	Neuville S Dromer F Morin O	2003	Clin Infect Dis2003，36，：	1
15	Determinants of disease presentation and outcome during eryptococcosis: the cryptoa/d study显示文摘	Dromer F Mathoulin-Pelissier S Launay O	2007	PLoS Med2007，4，2：	1
16	Clinical practice guidelines for the management of cryptococal disease:2010update by the infectious diseases society of America显示文摘	Perfect JR Dismukes WE Dromer F	2010	Clin Infect Dis2010，50，3：	1
17	Primary cutaneous crytococcosis: a distinct clinical entity显示文摘	Neuville S Dromer F Morin O	2003	Clin Infect Dis2003，36，3：	1
18	Cryptoeoccal neuroradiological le- sions severity during cryptococcal meningoencephalitis HIV-Positive pa- tients in the HAART Era显示文摘	Charlier C Dromer F Lvque C	2008	PLoS one2008，3，4：	1
19	Determinants of disease presentation and outcome during oryptococcosis , the CryptoA/D study 显示文摘	Dromer F Mathoulin-Pelissier S Launay 0	2007	PLoS Med2007，4，2：	1
20	Combination of amphotericin B with flucytosine is active in vitro against flucytosineresistant isolates of Cryptococcus neoformans antimierob显示文摘	Schwarz P Janbon G Dromer F	2007	Agents Chemother2007，51，：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示